Indoor Allergies: Pets

You love your pet. She makes you sneeze. Sound familiar? Well, you’re definitely not alone — almost 10 million people choose to keep cats or dogs in spite of their pet allergies.

What is it about pets that can cause nasal allergy symptoms? Their dander (skin particles), as well as their saliva and urine, can cause an allergic reaction. (Plus, pet hair is a good hiding place for other allergens such as pollen and dust.)

Tips to reduce nasal allergy symptoms
caused by cats and dogs

  • Experts say it's best not to let pets indoors if you have pet allergies. Of course, that may not be realistic. But do try to keep pets limited to a few rooms in your house — and at the very least, if you're allergic, keep pets out of your bedroom
  • Avoid wall-to-wall carpeting in areas where pets spend time. Opt for bare floors or washable area rugs instead
  • Avoid cleaning with harsh chemicals that can aggravate allergy symptoms
  • Use a vacuum with a HEPA filter
  • Keep a HEPA air cleaner running in your home
  • Cover spots on furniture where pets sleep or lie with something washable — and wash it frequently in hot water
  • Bathe pets once a week — studies have shown this significantly cuts down on the amount of dander that can cause symptoms. Look for special shampoos in pet stores that can help minimize allergens on your pet's skin
  • If you can, have someone else groom your pet or take it to the pet spa for regular grooming
  • Take steps to allergy-proof your home
Small Font
Medium Font
Large Font

email

print

Need to Allergy-Proof Your Home?

every time*

Find out how

Battling Asthma Too?

Give your home an allergy-proofing makeover.

Get started here

* Maximum savings of $50 on up to 12 prescription fills of OMNARIS per year. For qualifying patients. Restrictions apply. Full program rules.

OMNARIS (ciclesonide) Nasal Spray is for the treatment of nasal allergy symptoms associated with seasonal allergic rhinitis (seasonal allergies) in adults and children 6 years of age and older, and with perennial allergic rhinitis (year-round allergies) in adults and adolescents 12 and older.

Important Safety Information

Patients using corticosteroid drugs that weaken the immune system are more susceptible to infection and should avoid exposure to chickenpox or measles. If you have tuberculosis, eye herpes, or untreated infections of any kind, speak to your doctor before using OMNARIS. Yeast infections of the nose and throat may occur.

Patients who have recently had an ulcer in the nose, trauma to the nose or nasal surgery should not use OMNARIS until healing has occurred. Rare instances of nasal irritation and eye problems have been reported following the use of nasal steroids. Talk with your doctor if you have a history of eye problems or experience a change in vision.

Patients taking higher doses of a nasal steroid than recommended, or certain other at-risk individuals, may experience symptoms of a hormonal imbalance, including very rarely changes in menstruation, acne, and weight gain. Like all steroid nasal sprays, OMNARIS may cause slowed growth in children. The growth of children using OMNARIS should be monitored routinely by a healthcare professional.

The most common side effects that may occur with OMNARIS are headache, nosebleed, sore throat and ear pain.

The health information contained on this website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. The product discussed on this site may have different product labeling in different countries. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

For more information, please see the OMNARIS Full Prescribing Information and the OMNARIS Patient's Instructions for Use.

OMNARIS is available by prescription. Ask your healthcare professional if OMNARIS is right for you. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The health information contained on this website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. This site is intended for U.S. residents only. The product discussed on this site may have different product labeling in different countries. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

© 2011 Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Dainippon Sumitomo Pharma Co. Ltd., and is a registered trademark of Dainippon Sumitomo Pharma Co. Ltd.
OMNARIS is a registered trademark of Nycomed GmbH, used with permission.